TDOC
Teladoc Health, Inc.
6.10$
-0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 59.4% | 66.0% | 27.2% | 19.0% | 34.8% | 36.7% | 6.0% | 6.9% | 27.3% | 33.9% | 47.3% | 35.1% | |
| 50.5% | 24.0% | 16.5% | 5.2% | 27.7% | 32.1% | 4.1% | 5.0% | 19.5% | 25.6% | 36.9% | 25.2% | |
| 50.5% | 59.8% | 21.7% | 14.8% | 31.3% | 32.3% | 4.4% | 5.1% | 19.5% | 25.6% | 36.9% | 25.2% | |
| 7.7% | 5.3% | 4.5% | 3.3% | 2.8% | 3.6% | 1.0% | 1.1% | 5.0% | 5.2% | 6.4% | 6.5% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.3% | 0.4% | 1.2% | 0.7% | 1.1% | 1.2% | |
| 1.2% | 2.7% | 2.5% | 1.1% | 0.7% | 0.6% | 0.2% | 0.4% | 0.6% | – | – | – | |
| 30.9% | 24.5% | 62.0% | 60.5% | 48.2% | 46.5% | 82.1% | 81.8% | 22.8% | 24.4% | 8.1% | 9.1% | |
| 8.2% | 6.6% | 8.2% | 19.4% | 16.2% | 14.1% | 11.4% | 10.8% | 39.1% | 38.2% | 40.7% | 41.8% | |
| 42.1% | 22.3% | 24.0% | 32.2% | 33.7% | 36.7% | 10.5% | 9.5% | 50.9% | 47.0% | 57.6% | 55.3% | |
| 14.2% | 7.8% | 6.9% | 4.9% | 4.1% | 5.6% | 1.9% | 1.9% | 8.5% | 9.6% | 26.8% | 13.1% | |
| 0.9% | 0.5% | 0.7% | 3.4% | 0.2% | 0.3% | 0.3% | 0.1% | 0.3% | 0.2% | 16.0% | 0.4% | |
| 2.4% | 1.0% | 0.7% | 0.5% | 0.5% | 0.6% | 0.3% | 0.3% | 1.0% | 1.0% | 0.9% | 1.5% | |
| 27.4% | 11.0% | 14.0% | 25.2% | 27.1% | 27.5% | 7.8% | 6.9% | 32.7% | 35.0% | 28.2% | 32.1% | |
| 57.9% | 77.7% | 76.0% | 67.8% | 66.3% | 63.3% | 89.5% | 90.5% | 49.1% | 53.0% | 42.4% | 44.7% | |
| -78.8% | -56.8% | -67.4% | -37.8% | -26.7% | -31.7% | -5.6% | -8.0% | -319.3% | -346.7% | -461.5% | -529.9% | |
| 30.0% | 8.7% | 13.9% | 6.7% | 4.3% | 4.5% | 0.5% | 0.9% | 3.4% | 3.7% | 4.9% | 5.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.